伏立康唑
治疗药物监测
医学
队列
逻辑回归
入射(几何)
药品
内科学
重症监护医学
药理学
抗真菌
皮肤病科
物理
光学
作者
Jing Ma,Yu Wang,Shuang Ma,Jingsong Li
出处
期刊:
[Institute of Electrical and Electronics Engineers]
日期:2023-07-24
卷期号:2023: 1-4
被引量:5
标识
DOI:10.1109/embc40787.2023.10340343
摘要
Voriconazole is commonly used as the first-line agent to treat invasive fungal infections (IFIs), but the induction of hepatotoxicity limits its use. To improve the treatment outcomes and minimize toxicity, doctors often administer Therapeutic Drug Monitoring (TDM) to patients receiving voriconazole treatment. Here, we conducted a real-world clinical investigation of voriconazole-treated patients and found significant differences between the TDM (n=318) and non-TDM cohort (n=6,379), and such incidence of hepatotoxicity showed 10.6% in the non-TDM cohort, compared with 21.5% in the TDM cohort. Based on our previous investigation, we presented and compared several machine learning models (including AdaBoost, decision tree, GBDT, logistic regression, neural networks, and random forest) for the early warning of voriconazole-associated hepatoxicity. Through the five-fold cross validation, the logistic model outperformed other models with a mean AUC of 0.7933±0.0934. Our findings offer important insights into the safe and effective application of voriconazole.
科研通智能强力驱动
Strongly Powered by AbleSci AI